遗传性智力障碍儿童神经精神风险:IMAGINE英国全国队列研究
IMAGINE前瞻性队列纳入2770名4-19岁遗传性智力障碍儿童,与英格兰全国儿童心理健康调查比较。拷贝数变异遗传方式和社区社会经济剥夺均贡献神经精神风险。
要点
- 遗传性智力障碍儿童共病神经精神障碍风险显著高于一般人群。
- 拷贝数变异遗传性与社会经济剥夺均贡献神经精神风险。
核心结论
- 基因组变异合并智力障碍的儿童神经精神困难风险增高,拷贝数变异遗传性和社会经济剥夺也贡献风险。
研究设计与样本
- IMAGINE为前瞻性队列研究,2014年10月1日至2019年6月30日招募2770名4-19岁遗传性智力障碍儿童,来自3407名英国参与者。
- 通过NHS记录收集诊断基因组报告,由主要照护者完成DAWBA、SDQ、ABAS-3和病史问卷。
- 按邮编指数多重剥夺(IMD)对每名儿童排名,并与2017年英格兰全国儿童心理健康调查比较。
主要发现
- CNV儿童中,家族性变异者比新发变异者倾向于居住在社会经济更剥夺地区;遗传性和社会经济剥夺均贡献CNV者的神经精神风险。
临床怎么用
- 对智力障碍儿童早期进行基因组学检查可能有助于识别最脆弱儿童。
- 利用家长专业知识通过在线DAWBA评估可快速识别有特殊需要的儿童并转介儿童心理健康服务。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Children with intellectual disability frequently have multiple co-morbid neuropsychiatric conditions and poor physical health. Genomic testing is increasingly recommended as a first-line investigation for these children. We aim to determine the effect of genomics, inheritance, and socioeconomic deprivation on neuropsychiatric risk in children with intellectual disability of genetic origin as compared with the general population. METHODS: IMAGINE is a prospective cohort study using online mental health and medical assessments in a cohort of 3407 UK participants with intellectual disability and pathogenic genomic variants as identified by the UK's National Health Service (NHS). Our study is on a subset of these participants, including all children aged 4-19 years. We collected diagnostic genomic reports from NHS records and asked primary caregivers to provide an assessment of their child using the Development and Well-Being Assessment (DAWBA), the Strengths and Difficulties Questionnaire (SDQ), the Adaptive Behaviour Assessment System 3 (ABAS-3), and a medical history questionnaire. Each child was assigned a rank based on their postcode using the index of multiple deprivation (IMD). We compared the IMAGINE cohort with the 2017 National Survey of Children's Mental Health in England. The main outcomes of interest were mental health and neurodevelopment according to the DAWBA and SDQ. FINDINGS: We recruited 2770 children from the IMAGINE study between Oct 1, 2014 and June 30, 2019, of whom 2397 (86·5%) had a basic assessment of their mental health completed by their families and 1277 (46·1%) completed a medical history questionnaire. The mean age of participants was 9·2 years (SD 3·9); 1339 (55·9%) were boys and 1058 (44·1%) were girls. 355 (27·8%) of 1277 reported a seizure disorder and 814 (63·7%) reported movement or co-ordination problems. 1771 (73·9%) of 2397 participants had a pathogenic copy number variant (CNV) and 626 (26·1%) had a pathogenic single nucleotide variant (SNV). Participants were representative of the socioeconomic spectrum of the UK general population. The relative risk (RR) of co-occurring neuropsychiatric diagnoses, compared with the English national population, was high: autism spectrum disorder RR 29·2 (95% CI 23·9-36·5), ADHD RR 13·5 (95% CI 11·1-16·3). In children with a CNV, those with a familial variant tended to live in more socioeconomically deprived areas than those with a de novo variant. Both inheritance and socioeconomic deprivation contributed to neuropsychiatric risk in those with a CNV. INTERPRETATION: Children with genomic variants and intellectual disability are at an increased risk of neuropsychiatric difficulties. CNV variant inheritance and socioeconomic deprivation also contribute to the risk. Early genomic investigations of children with intellectual disability could facilitate the identification of the most vulnerable children. Additionally, harnessing parental expertise using online DAWBA assessments could rapidly identify children with exceptional needs to child mental health services. FUNDING: UK Medical Research Council and Medical Research Foundation.
引用
- Wolstencroft J, Wicks F, Srinivasan R, et al. Neuropsychiatric risk in children with intellectual disability of genetic origin: IMAGINE, a UK national cohort study. Lancet Psychiatry. 2022. PMID: 35932790. doi:10.1016/S2215-0366(22)00207-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。